NILOTINIB 300 MG TWICE DAILY IS EFFECTIVE AND WELL TOLERATED AS FIRST LINE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: UPDATED RESULTS OF THE ICORG 0802 PHASE 2 STUDY

E. O'Dwyer; R. Swords; F. Giles; P. LeCoutre; Mary Frances McMullin; S. Langabeer; S. Padmanabhan; E. Kent; M. Parker; B. Moulton; K. Egan; E. Conneally

NILOTINIB 300 MG TWICE DAILY IS EFFECTIVE AND WELL TOLERATED AS FIRST LINE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: UPDATED RESULTS OF THE ICORG 0802 PHASE 2 STUDY

E. O'Dwyer, R. Swords, F. Giles, P. LeCoutre, Mary Frances McMullin, S. Langabeer, S. Padmanabhan, E. Kent, M. Parker, B. Moulton, K. Egan, E. Conneally

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	340-340
Number of pages	1
Journal	HAEMATOLOGICA
Volume	95
Publication status	Published - Jun 2010

Cite this

O'Dwyer, E., Swords, R., Giles, F., LeCoutre, P., McMullin, M. F., Langabeer, S., Padmanabhan, S., Kent, E., Parker, M., Moulton, B., Egan, K., & Conneally, E. (2010). NILOTINIB 300 MG TWICE DAILY IS EFFECTIVE AND WELL TOLERATED AS FIRST LINE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: UPDATED RESULTS OF THE ICORG 0802 PHASE 2 STUDY. HAEMATOLOGICA, 95, 340-340.

@article{14a652527ee049cd82865708232d2b39,

title = "NILOTINIB 300 MG TWICE DAILY IS EFFECTIVE AND WELL TOLERATED AS FIRST LINE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: UPDATED RESULTS OF THE ICORG 0802 PHASE 2 STUDY",

author = "E. O'Dwyer and R. Swords and F. Giles and P. LeCoutre and McMullin, {Mary Frances} and S. Langabeer and S. Padmanabhan and E. Kent and M. Parker and B. Moulton and K. Egan and E. Conneally",

year = "2010",

month = jun,

language = "English",

volume = "95",

pages = "340--340",

journal = "HAEMATOLOGICA",

issn = "1592-8721",

publisher = "Ferrata Storti Foundation",

}

O'Dwyer, E, Swords, R, Giles, F, LeCoutre, P, McMullin, MF, Langabeer, S, Padmanabhan, S, Kent, E, Parker, M, Moulton, B, Egan, K & Conneally, E 2010, 'NILOTINIB 300 MG TWICE DAILY IS EFFECTIVE AND WELL TOLERATED AS FIRST LINE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: UPDATED RESULTS OF THE ICORG 0802 PHASE 2 STUDY', HAEMATOLOGICA, vol. 95, pp. 340-340.

TY - JOUR

T1 - NILOTINIB 300 MG TWICE DAILY IS EFFECTIVE AND WELL TOLERATED AS FIRST LINE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: UPDATED RESULTS OF THE ICORG 0802 PHASE 2 STUDY

AU - O'Dwyer, E.

AU - Swords, R.

AU - Giles, F.

AU - LeCoutre, P.

AU - McMullin, Mary Frances

AU - Langabeer, S.

AU - Padmanabhan, S.

AU - Kent, E.

AU - Parker, M.

AU - Moulton, B.

AU - Egan, K.

AU - Conneally, E.

PY - 2010/6

Y1 - 2010/6

M3 - Article

SN - 1592-8721

VL - 95

SP - 340

EP - 340

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

ER -